Grifols, S.A.

Grifols, S.A.verified

GRFS

Price:

$8.8

Market Cap:

$6.44B

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2011-06-02

Stock Exchange

NASDAQ

Ticker

GRFS

The ROE as of November 2024 (TTM) for Grifols, S.A. (GRFS) is 2.58%

According to Grifols, S.A.’s latest financial reports and current stock price. The company's current ROE is 2.58%. This represents a change of 304.12% compared to the average of 0.64% of the last 4 quarters.

Grifols, S.A. (GRFS) Historical ROE (quarterly & annually)

How has GRFS ROE performed in the past?

The mean historical ROE of Grifols, S.A. over the last ten years is 11.47%. The current 2.58% ROE has changed -77.47% with respect to the historical average. Over the past ten years (40 quarters), GRFS's ROE was at its highest in in the September 2022 quarter at 11.82%. The ROE was at its lowest in in the September 2021 quarter at -0.71%.

Quarterly (TTM)
Annual

Average

11.47%

Median

13.54%

Minimum

1.02%

Maximum

18.26%

Grifols, S.A. (GRFS) ROE by Quarter and Year

Discovering the peaks and valleys of Grifols, S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 24.59%

Maximum Annual ROE = 18.26%

Minimum Annual Increase = -70.04%

Minimum Annual ROE = 1.02%

Quarterly (TTM)
Annual
YearROEChange
20231.02%-70.04%
20223.40%-21.93%
20214.35%-64.06%
202012.11%-6.60%
201912.96%-8.19%
201814.12%-22.68%
201718.26%24.59%
201614.66%-9.21%
201516.14%-8.74%
201417.69%7.58%

Grifols, S.A. (GRFS) Average ROE

How has GRFS ROE performed in the past?

The current ROE of Grifols, S.A. (GRFS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.92%

5-year avg

6.77%

10-year avg

11.47%

Grifols, S.A. (GRFS) ROE vs. Peers

How is GRFS’s ROE compared to its peers?

Grifols, S.A.’s ROE is less than Novartis AG (41.08%), less than AstraZeneca PLC (16.80%), less than GSK plc (18.08%), less than Roche Holding AG (54.68%), greater than Bristol-Myers Squibb Company (-36.26%), less than Merck & Co., Inc. (29.85%), less than Gilead Sciences, Inc. (5.21%), less than Amgen Inc. (68.49%), less than Biogen Inc. (10.25%), less than Sanofi (10.71%),

CompanyROEMarket cap
41.08%$216.23B
16.80%$221.47B
18.08%$75.40B
54.68%$257.13B
-36.26%$112.46B
29.85%$258.22B
5.21%$111.85B
68.49%$170.35B
10.25%$25.29B
10.71%$132.76B

Build a custom stock screener for Grifols, S.A. (GRFS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grifols, S.A. (GRFS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Grifols, S.A.'s ROE?

How is the ROE calculated for Grifols, S.A. (GRFS)?

What is the highest ROE for Grifols, S.A. (GRFS)?

What is the 3-year average ROE for Grifols, S.A. (GRFS)?

What is the 5-year average ROE for Grifols, S.A. (GRFS)?

How does the current ROE for Grifols, S.A. (GRFS) compare to its historical average?